Exogenous MOTS-c can inhibit OC cell growth in vitro and in vivo. Mechanistically, MOTS-c exerted anti-cancer effects by attenuating USP7-mediated deubiquitination of LARS1 and promoting LARS1 degradation. Our study revealed for the first time that MOTS-c serves as an antitumor peptide to inhibit OC progression, and thus could be a potential target for future OC diagnosis and treatment.
Click to expand...
It looks like a promising anti-cancer agent, (in the paper, 'OC' stands for Ovarian Cancer) although so far it has only been tested in mice and petri dishes.
I won't claim to understand even 10% of it, but here are the details -
Chinese research paper.